Product

Ibrexafungerp Citrate - API

Product Name Ibrexafungerp Citrate - API
Product Code DA-I140-a
Chemical name Ibrexafungerp Citrate
Synonyms SCY 078 Citrate; MK-3118; 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-, (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); (1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-2-((R)-2-Amino-2,3,3-trimethylbutoxy)-1,6a,8,10a-tetramethyl-8-((R)-3-methylbutan-2-yl)-3-(5-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid compound with 2-hydroxypropane-1,2,3-tricarboxylic acid (1:1);
Impurity NA
CAS Number 1965291-08-0
Alternate CAS # NA
Molecular form C50H75N5O11
Appearance NA
Melting Point NA
Mol. Weight 922.17
Storage 2-8°C Refrigerator
Solubility NA
Stability NA
Category pharmaceutical standards,intermediates,Fine Chemicals
Boiling Point NA
Applications Ibrexafungerp, also known as SCY-078 or MK-3118, is a novel enfumafungin derivative oral triterpene antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as a vaginal yeast infection.It was developed out of a need to treat fungal infections that may have become resistant to echinocandins or azole antifungals.
Dangerous Goods Info NA
References NA
Extra Notes NA
Documents (MSDS) No Data Available
Keywords NA
Product Packings